Nanopublications

Matches in Nanopublications for { ?s ?p "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 100 of ±580 with 100 items per page.

assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP92201.RAWd_lLE0JLn5i9MqlfwDfswHHPov2zNko6yzXb-R53Ow130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92201.RAWd_lLE0JLn5i9MqlfwDfswHHPov2zNko6yzXb-R53Ow130_provenance.
NP92204.RAcWqgdntioCsAThwlihuI_ScyYRM2J7PM95yV2hd1_04130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92204.RAcWqgdntioCsAThwlihuI_ScyYRM2J7PM95yV2hd1_04130_provenance.
NP92210.RAck_aB_vpDROthdW2MjMMxKRnwC55HUoRuaR6te-n6ow130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92210.RAck_aB_vpDROthdW2MjMMxKRnwC55HUoRuaR6te-n6ow130_provenance.
NP92243.RAe5rHzVkEFnL_FihrpXoq1OwZoqHtU61Q0PitxbeFqD0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92243.RAe5rHzVkEFnL_FihrpXoq1OwZoqHtU61Q0PitxbeFqD0130_provenance.
NP92245.RAZImAhuo4oyTKEA6KEgSFPhsL2P6FAVxdOodxDiIER9U130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92245.RAZImAhuo4oyTKEA6KEgSFPhsL2P6FAVxdOodxDiIER9U130_provenance.
NP92250.RAb0bzfP9K8cwV0fnWTo-C6nx-RRcojpBAHhUsmtbEsXY130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92250.RAb0bzfP9K8cwV0fnWTo-C6nx-RRcojpBAHhUsmtbEsXY130_provenance.
NP92265.RARSPjJ_Caa9AcGoxl4DRAUpXMc6YIyc-FkQ3sSJ3lxnQ130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92265.RARSPjJ_Caa9AcGoxl4DRAUpXMc6YIyc-FkQ3sSJ3lxnQ130_provenance.
NP92267.RAbZMyPiyFFa7Q9pZTXWQvWAVtQmtoGY-uebLZam0NDUs130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92267.RAbZMyPiyFFa7Q9pZTXWQvWAVtQmtoGY-uebLZam0NDUs130_provenance.
NP92314.RAWZfsnTXBxHu792iut0UutJgqeT1luGZbemb6RiZdKGU130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92314.RAWZfsnTXBxHu792iut0UutJgqeT1luGZbemb6RiZdKGU130_provenance.
NP92335.RAfMjvWuUkVj1HojHONPCmVlzM7skLK4lmX2TAFSKtdOM130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92335.RAfMjvWuUkVj1HojHONPCmVlzM7skLK4lmX2TAFSKtdOM130_provenance.
NP92341.RAdDlF1xeWsDie66M02TElbNLyqN6jxqN0P6ag2TARRmY130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92341.RAdDlF1xeWsDie66M02TElbNLyqN6jxqN0P6ag2TARRmY130_provenance.
NP92413.RAaRCkh7M59ZeKjk8j4IlRKAqVgV5lD-kLVNim2I64HHY130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92413.RAaRCkh7M59ZeKjk8j4IlRKAqVgV5lD-kLVNim2I64HHY130_provenance.
NP92536.RAYaDOVemo5UUiE9arnUKdPoZYoWilMrhyvMvQkBgsrMA130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92536.RAYaDOVemo5UUiE9arnUKdPoZYoWilMrhyvMvQkBgsrMA130_provenance.
NP92537.RASFuwDzzvxkaPq8fb8bkdI6PL0OEwv3QGGg2sO-3WZlc130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92537.RASFuwDzzvxkaPq8fb8bkdI6PL0OEwv3QGGg2sO-3WZlc130_provenance.
NP89427.RAnhHl_r2YFTnvdhkPSlO9bg9ryRUPzHZh7dXJHvacBMo130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89427.RAnhHl_r2YFTnvdhkPSlO9bg9ryRUPzHZh7dXJHvacBMo130_provenance.
NP91711.RAlag-xytCt6ILD5wsj173zfhcykBTvigWcoYp5JHMmEE130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91711.RAlag-xytCt6ILD5wsj173zfhcykBTvigWcoYp5JHMmEE130_provenance.
NP91920.RAhOXXkfYvz413_3-3qOid_5hSGLLb3EWjVXRpAei5uzM130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91920.RAhOXXkfYvz413_3-3qOid_5hSGLLb3EWjVXRpAei5uzM130_provenance.
NP92208.RAlt3UV52oe0ujYV4vp6NBBRLzsb7dg20959D1wGXIw10130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92208.RAlt3UV52oe0ujYV4vp6NBBRLzsb7dg20959D1wGXIw10130_provenance.
NP92213.RAque2aezpdNoPROCq-Y2PPHPcklC_cWrtsqZSA6ZlhJ4130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92213.RAque2aezpdNoPROCq-Y2PPHPcklC_cWrtsqZSA6ZlhJ4130_provenance.
NP92239.RAon2s85NQ0REpMTWqmmez_lt1vRB1BEoQYXinlaSJuYU130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92239.RAon2s85NQ0REpMTWqmmez_lt1vRB1BEoQYXinlaSJuYU130_provenance.
NP92244.RApvQZHNSNQLZBD7kH4saL06bBxAK1fiyvRN1ZVdJg-Hg130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92244.RApvQZHNSNQLZBD7kH4saL06bBxAK1fiyvRN1ZVdJg-Hg130_provenance.
NP92251.RAqy2K9KSStmUlp7UWjKTkWDXonuXR1UiVE-sJZibFrKE130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92251.RAqy2K9KSStmUlp7UWjKTkWDXonuXR1UiVE-sJZibFrKE130_provenance.
NP92254.RAiI8UAgdPAdkFa9u9dIrQPFcAqcs4Fo9a3Xpec6tkumw130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92254.RAiI8UAgdPAdkFa9u9dIrQPFcAqcs4Fo9a3Xpec6tkumw130_provenance.
NP92270.RAtc06hlsUz53erDPpLPBU1WBjhGgqoo_TaXiTUzzBN68130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92270.RAtc06hlsUz53erDPpLPBU1WBjhGgqoo_TaXiTUzzBN68130_provenance.
NP92322.RAqgvyE4qJCUTu5cyGL6SUPGE9G-GvwuHFGL09z8es8ME130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92322.RAqgvyE4qJCUTu5cyGL6SUPGE9G-GvwuHFGL09z8es8ME130_provenance.
NP92334.RAhknoDmwaLBEB_qn6QsXVLeDY7QV66t9XrJ83fHXd9i4130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92334.RAhknoDmwaLBEB_qn6QsXVLeDY7QV66t9XrJ83fHXd9i4130_provenance.
NP92349.RAgdLIy28N51n484irLXGM_PKSo3NJ97BvChjIzHdtstE130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92349.RAgdLIy28N51n484irLXGM_PKSo3NJ97BvChjIzHdtstE130_provenance.
NP92353.RArgLbq90YvBMqPHlhrK9_I1Jah6ix_6q2o3CPen2YZ9Y130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92353.RArgLbq90YvBMqPHlhrK9_I1Jah6ix_6q2o3CPen2YZ9Y130_provenance.
NP92439.RAudPp_doZIIyFHK9goYxcK7vbPOMohYgXaHvaZ7EFcpg130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92439.RAudPp_doZIIyFHK9goYxcK7vbPOMohYgXaHvaZ7EFcpg130_provenance.
NP83057.RAMH8EpU5KEMAf3S2lUgH7YtGxc2oOLSPswzJ8BcnQm9o130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83057.RAMH8EpU5KEMAf3S2lUgH7YtGxc2oOLSPswzJ8BcnQm9o130_provenance.
NP83653.RAKomXyq44kSvXn4scEOpToHQdyqL2NMGpjhvxyEQ618o130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83653.RAKomXyq44kSvXn4scEOpToHQdyqL2NMGpjhvxyEQ618o130_provenance.
NP83785.RAL7w-Sj4kz6se4MGrlFuhj89zRtGL7hGmAmWN8jzBNnY130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83785.RAL7w-Sj4kz6se4MGrlFuhj89zRtGL7hGmAmWN8jzBNnY130_provenance.
NP85527.RADzNoWRZ6rb9tBDuQ9Vc3rAGFv0IwHNBAydz9Bsg5dwo130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85527.RADzNoWRZ6rb9tBDuQ9Vc3rAGFv0IwHNBAydz9Bsg5dwo130_provenance.
NP87052.RACldfIPZl9uJQYyaN6udJfhLtkeIbCwBNloBvfqcEF2w130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87052.RACldfIPZl9uJQYyaN6udJfhLtkeIbCwBNloBvfqcEF2w130_provenance.
NP87706.RACitnQ1b4m8BLpRWKrRYcwH60QB4saGAnZ47g7gQlAr0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87706.RACitnQ1b4m8BLpRWKrRYcwH60QB4saGAnZ47g7gQlAr0130_provenance.
NP91002.RABVKkGL38bwiNFq4CTyR-5fk-4pvK_xfJRHBYjbddroo130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91002.RABVKkGL38bwiNFq4CTyR-5fk-4pvK_xfJRHBYjbddroo130_provenance.
NP91215.RAD7Afphi2j0xWetmcak0l79CXyqnrNVDi38VL7xcIvMc130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91215.RAD7Afphi2j0xWetmcak0l79CXyqnrNVDi38VL7xcIvMc130_provenance.
NP91342.RADhyEuh2Nv5cl8EZ3fXqXTm_dId2a1xe11seS8ms_MKU130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91342.RADhyEuh2Nv5cl8EZ3fXqXTm_dId2a1xe11seS8ms_MKU130_provenance.
NP92462.RACXb6r3-BrTm36XRhHtzAuXDT5FXfV0VeJjn5vCdD4lk130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92462.RACXb6r3-BrTm36XRhHtzAuXDT5FXfV0VeJjn5vCdD4lk130_provenance.
NP92468.RADMfsQzUhyvPkYWn9K_I99EEN5M63PL2fvteBbDukfyg130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92468.RADMfsQzUhyvPkYWn9K_I99EEN5M63PL2fvteBbDukfyg130_provenance.
NP83589.RAxHHdCtLsizEn1ns3SXol8u9jdQ53amK2t7tRg_wieyc130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83589.RAxHHdCtLsizEn1ns3SXol8u9jdQ53amK2t7tRg_wieyc130_provenance.
NP83784.RAyV8Aupm3UsCGI3QLRLsWXJxgHrwzhQWV4FGcQaKzBgM130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83784.RAyV8Aupm3UsCGI3QLRLsWXJxgHrwzhQWV4FGcQaKzBgM130_provenance.
NP84617.RA-WlpYowdjuV7BNzY5XCNOayYo0j308lBvZJaSCHPbSU130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84617.RA-WlpYowdjuV7BNzY5XCNOayYo0j308lBvZJaSCHPbSU130_provenance.
NP85395.RA0-tOHMYMGL8jGkaj5ERrx572nWugTT4t9ptbL92cPQY130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85395.RA0-tOHMYMGL8jGkaj5ERrx572nWugTT4t9ptbL92cPQY130_provenance.
NP85496.RA3ZKkq-aoCJCmZ8kYXBlTndiLfoi8zwTQSsXWWKch384130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85496.RA3ZKkq-aoCJCmZ8kYXBlTndiLfoi8zwTQSsXWWKch384130_provenance.
NP85719.RA2WLbLYDna8xTQByutJATNdQpMVvQ1_3mUhrYvrukuM0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85719.RA2WLbLYDna8xTQByutJATNdQpMVvQ1_3mUhrYvrukuM0130_provenance.
NP85777.RAxNYSUt2dOr0ya55ZGBwTBp_k1oDFpnTjDuvO1Qf3Auo130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85777.RAxNYSUt2dOr0ya55ZGBwTBp_k1oDFpnTjDuvO1Qf3Auo130_provenance.
NP85784.RA9FPXdioNzgP21xET924eXBlRLn-sUSyayDteQCTZrhk130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85784.RA9FPXdioNzgP21xET924eXBlRLn-sUSyayDteQCTZrhk130_provenance.
NP85789.RA-2RKapqqpkJ_D-33bGe0dENoUJP987uT4QpSM-f9-5s130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85789.RA-2RKapqqpkJ_D-33bGe0dENoUJP987uT4QpSM-f9-5s130_provenance.
NP86287.RA89ZiD-ghOK-5onC3-65hURoCVoH2NfpLumlJoPkSB8M130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86287.RA89ZiD-ghOK-5onC3-65hURoCVoH2NfpLumlJoPkSB8M130_provenance.
NP86836.RA5vlEKnQmZ-xQuMmzBhuwe1nZa8xYgETXD451Kh-zZF4130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86836.RA5vlEKnQmZ-xQuMmzBhuwe1nZa8xYgETXD451Kh-zZF4130_provenance.
NP86837.RA7-NnIkH0iieoQ4WmF2oaoeAwLHUzZWVDCRBZbtDGUJ0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86837.RA7-NnIkH0iieoQ4WmF2oaoeAwLHUzZWVDCRBZbtDGUJ0130_provenance.
NP87064.RA8td5Sj6RTCWZuHMRyCkf40PWqJnSql0PwhfskNJcDoU130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87064.RA8td5Sj6RTCWZuHMRyCkf40PWqJnSql0PwhfskNJcDoU130_provenance.
NP87642.RA2HocU9fikcrpANR4dFpeon51tajqa1bLj1CUbStTUA4130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87642.RA2HocU9fikcrpANR4dFpeon51tajqa1bLj1CUbStTUA4130_provenance.
NP87707.RA0BFHW0rADb59djVZSVe7UnJFOrHqArlIX05uP8Le2VM130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87707.RA0BFHW0rADb59djVZSVe7UnJFOrHqArlIX05uP8Le2VM130_provenance.
NP88094.RA50IZZbkOX1AyNfrWF4qIlGy1Gn_U6qhXUtMqE-t1M-4130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88094.RA50IZZbkOX1AyNfrWF4qIlGy1Gn_U6qhXUtMqE-t1M-4130_provenance.
NP90771.RA95tctvwXnTa-T3ZX7bGCKpGCws4RLWMoNULZ-LoERRE130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90771.RA95tctvwXnTa-T3ZX7bGCKpGCws4RLWMoNULZ-LoERRE130_provenance.
NP90879.RA3lAqMU7yVSFvAPmA4Cxg1mg8Zao7MstBA3ObuLTgQsw130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90879.RA3lAqMU7yVSFvAPmA4Cxg1mg8Zao7MstBA3ObuLTgQsw130_provenance.
NP91302.RA4gcv5vUMCNLC8RX07e_EVBBjBqNRP-VqthesnRT83tE130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91302.RA4gcv5vUMCNLC8RX07e_EVBBjBqNRP-VqthesnRT83tE130_provenance.
NP91341.RA0RJSJSbcOKChSC4jKmV3lw2I13aaEG3miM9dM-M4ESQ130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91341.RA0RJSJSbcOKChSC4jKmV3lw2I13aaEG3miM9dM-M4ESQ130_provenance.
NP91481.RA4mDnm_aDVzcPzrg-iE55FtRz7TG-SbVo5dCtvuDlESk130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91481.RA4mDnm_aDVzcPzrg-iE55FtRz7TG-SbVo5dCtvuDlESk130_provenance.
NP91504.RA7Wq8k5q7EXHbJYCjMTJM_F1dru3qr0O4nsAwJVckuXA130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91504.RA7Wq8k5q7EXHbJYCjMTJM_F1dru3qr0O4nsAwJVckuXA130_provenance.
NP92078.RA7pB-QYA6nGWoOxASrcGf84uPuvxuvjkRTK1CcAeI2zw130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92078.RA7pB-QYA6nGWoOxASrcGf84uPuvxuvjkRTK1CcAeI2zw130_provenance.
NP92103.RAxALlNdD-yRNb3zP-ELxnUqAITEDWk5vjFHe_gSyUgy0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92103.RAxALlNdD-yRNb3zP-ELxnUqAITEDWk5vjFHe_gSyUgy0130_provenance.
NP85328.RAfHKc6oL3tZVPzUilowOcZPZXt36cj2joDxQOazZhx6Q130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85328.RAfHKc6oL3tZVPzUilowOcZPZXt36cj2joDxQOazZhx6Q130_provenance.
NP85519.RAYBeWCYYlCkhm7YblMw0WPzYv7Pxiv0rjDVpzJnzgc98130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85519.RAYBeWCYYlCkhm7YblMw0WPzYv7Pxiv0rjDVpzJnzgc98130_provenance.
NP85557.RAVKJf5QyQyVVg8g_WDxrh0T5972_xQXqinZfH9zAe_js130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85557.RAVKJf5QyQyVVg8g_WDxrh0T5972_xQXqinZfH9zAe_js130_provenance.
NP85773.RAWLXtHWhEKosD928hS0b8mkvgoS_b_R1P4YGlxmOAe5k130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85773.RAWLXtHWhEKosD928hS0b8mkvgoS_b_R1P4YGlxmOAe5k130_provenance.
NP87043.RAX2ewO199btd25XbA3xXjDiFgPcpeji4qiKAWtj6WxbM130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87043.RAX2ewO199btd25XbA3xXjDiFgPcpeji4qiKAWtj6WxbM130_provenance.
NP87047.RAVVOBm4SvuDYw2C3tGY1eCa1UuswVv5LjTzGlbMonpoE130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87047.RAVVOBm4SvuDYw2C3tGY1eCa1UuswVv5LjTzGlbMonpoE130_provenance.
NP87059.RAbkI63_KspmpbTZ-BGc1gReR-Tlkx9VjNLLygbh3ALR0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87059.RAbkI63_KspmpbTZ-BGc1gReR-Tlkx9VjNLLygbh3ALR0130_provenance.
NP87168.RAeCVCu7J7GML-eW8XY9lvZPxP0ZEjeaC7T0HavEGe-Ik130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87168.RAeCVCu7J7GML-eW8XY9lvZPxP0ZEjeaC7T0HavEGe-Ik130_provenance.
NP87643.RAbZMmZFwKcEabwBXf1mQPuLLY-gWZilphfwR8uh0PEtc130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87643.RAbZMmZFwKcEabwBXf1mQPuLLY-gWZilphfwR8uh0PEtc130_provenance.
NP87696.RAc2lTavYtoT6Q0LoQzX5IhKfZ71iVYxl02M2hx0i9AD0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87696.RAc2lTavYtoT6Q0LoQzX5IhKfZ71iVYxl02M2hx0i9AD0130_provenance.
NP87951.RAco3Nn0XRRzv6EDXT7iiXpwxvARw65Th6dM-Gx7Ea0mE130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87951.RAco3Nn0XRRzv6EDXT7iiXpwxvARw65Th6dM-Gx7Ea0mE130_provenance.
NP89536.RAd-UoQ7YAgQga1UQy-W3ACScazYzLacAlNMfBxe5YkG0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89536.RAd-UoQ7YAgQga1UQy-W3ACScazYzLacAlNMfBxe5YkG0130_provenance.
NP90455.RAaxbMQqCEuxwVBPH3FHmpltTfKJx8wrhlqBZ_mufXsfc130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90455.RAaxbMQqCEuxwVBPH3FHmpltTfKJx8wrhlqBZ_mufXsfc130_provenance.
NP90654.RAcnRePSnMfsacMTP_8NJ00snVGeu9Poy1TprPCu5xq34130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90654.RAcnRePSnMfsacMTP_8NJ00snVGeu9Poy1TprPCu5xq34130_provenance.
NP90976.RAYXMLxUTHbopv9qeLu1rPTPyq6EL2x-lvdWNq5YtEeCE130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90976.RAYXMLxUTHbopv9qeLu1rPTPyq6EL2x-lvdWNq5YtEeCE130_provenance.
assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP83126.RAYJOu9E5GK-rHbbtBthGr1LMh28rLCbHINLi6oUznqqQ130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83126.RAYJOu9E5GK-rHbbtBthGr1LMh28rLCbHINLi6oUznqqQ130_provenance.
NP83244.RAfTswdyXt2A5b60BCSvYdNXIyMRufVACErBrdKnX4hMc130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83244.RAfTswdyXt2A5b60BCSvYdNXIyMRufVACErBrdKnX4hMc130_provenance.
NP83434.RASYKNaoEnB-zsduYXyxat5Ynt_7EAF4KyxHl4YLX0tQU130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83434.RASYKNaoEnB-zsduYXyxat5Ynt_7EAF4KyxHl4YLX0tQU130_provenance.
NP83472.RASFBAGL2SbcZJkQ0eVc7i1OTgDPreYE9-RL6nFo-sjY0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83472.RASFBAGL2SbcZJkQ0eVc7i1OTgDPreYE9-RL6nFo-sjY0130_provenance.
NP83594.RAQKE85JqcCminLVg2brn6NiznFiiqNDc2o51xe8MMTfc130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83594.RAQKE85JqcCminLVg2brn6NiznFiiqNDc2o51xe8MMTfc130_provenance.
NP83619.RAeCWFULL3GujmkE2-mmMwJBi5ZPxeVw248o0r2sGnEzw130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83619.RAeCWFULL3GujmkE2-mmMwJBi5ZPxeVw248o0r2sGnEzw130_provenance.
NP83655.RAW7xFIsDHix-oqo5BG1bKDAEfmCH-dmcVcpWS28eWneY130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83655.RAW7xFIsDHix-oqo5BG1bKDAEfmCH-dmcVcpWS28eWneY130_provenance.
NP84166.RAQFSssXK1qSZ82V4414UfFDDay3b8aNK08vafbvbr8sg130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP84166.RAQFSssXK1qSZ82V4414UfFDDay3b8aNK08vafbvbr8sg130_provenance.
NP92197.RAwiBUtqw04guTSodDgyY6PKuIDrvd7EaRfk4YZijQJt0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92197.RAwiBUtqw04guTSodDgyY6PKuIDrvd7EaRfk4YZijQJt0130_provenance.
NP92212.RA4UQm-4hTiiLxOIjDUcFybwSjT7g-ZeZlFaBpP8CNtdo130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92212.RA4UQm-4hTiiLxOIjDUcFybwSjT7g-ZeZlFaBpP8CNtdo130_provenance.
NP92284.RA-_u_Ohwwu5j1XS0w5iq9V2qTXFmOWEEv3P42FIm3it8130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92284.RA-_u_Ohwwu5j1XS0w5iq9V2qTXFmOWEEv3P42FIm3it8130_provenance.
NP92340.RA9ZCineqC-4wNLbcvSciENz-FpmS0xDNhI9CuUfMIhgc130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92340.RA9ZCineqC-4wNLbcvSciENz-FpmS0xDNhI9CuUfMIhgc130_provenance.
NP92343.RA4r0GZETjYfzs2Hm2t0MQlNHGhfxW118zdMY8R-kFQL0130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92343.RA4r0GZETjYfzs2Hm2t0MQlNHGhfxW118zdMY8R-kFQL0130_provenance.
NP92502.RA1yil3yWbTeZdlzfmFQLAmPNaMluGoOVddnc_23CvtVY130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92502.RA1yil3yWbTeZdlzfmFQLAmPNaMluGoOVddnc_23CvtVY130_provenance.
NP91260.RAWRcAts8QO0TXuN1QO_6XVFJLtpUREJWINCHZitaqnTc130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91260.RAWRcAts8QO0TXuN1QO_6XVFJLtpUREJWINCHZitaqnTc130_provenance.
NP91493.RAR2i70MCJgRpaZZVAcCXU-ghGpyb04bu-I7Rf0Lwj9Uw130_assertion description "[These results suggest that CACNA1C may be associated with secondary hyperparathyroidism. In addition, the haplotype-based approach may be useful to screen for key molecules associated with complex traits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91493.RAR2i70MCJgRpaZZVAcCXU-ghGpyb04bu-I7Rf0Lwj9Uw130_provenance.